BLTE insider transactions
Belite Bio Inc (BLTE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for BLTE
- Chief Scientific Officer Mata Nathan L. sold $102,039 worth of American depositary share (666 units at $153.21) as part of a pre-agreed trading plan, closing all direct ownership in the company (SEC Form 4)4 - BELITE BIO, INC (0001889109) (Issuer)
- Chief Scientific Officer Mata Nathan L. sold $153,839 worth of American depositary share (1,000 units at $153.84) as part of a pre-agreed trading plan, decreasing direct ownership by 60% to 666 units (SEC Form 4)4 - BELITE BIO, INC (0001889109) (Issuer)
- Chief Scientific Officer Mata Nathan L. sold $155,502 worth of American depositary share (1,000 units at $155.50) as part of a pre-agreed trading plan, decreasing direct ownership by 38% to 1,666 units (SEC Form 4)4 - BELITE BIO, INC (0001889109) (Issuer)
- Chief Scientific Officer Mata Nathan L. sold $155,636 worth of American depositary share (1,000 units at $155.64) as part of a pre-agreed trading plan, decreasing direct ownership by 27% to 2,666 units (SEC Form 4)4 - BELITE BIO, INC (0001889109) (Issuer)
- Chief Scientific Officer Mata Nathan L. sold $155,778 worth of American depositary share (1,000 units at $155.78) as part of a pre-agreed trading plan, decreasing direct ownership by 21% to 3,666 units (SEC Form 4)4 - BELITE BIO, INC (0001889109) (Issuer)
- Chief Scientific Officer Mata Nathan L. sold $156,973 worth of American depositary share (1,000 units at $156.97) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 4,666 units (SEC Form 4)4 - BELITE BIO, INC (0001889109) (Issuer)
- Chief Scientific Officer Mata Nathan L. sold $155,817 worth of American depositary share (1,000 units at $155.82) as part of a pre-agreed trading plan, decreasing direct ownership by 15% to 5,666 units (SEC Form 4)4 - BELITE BIO, INC (0001889109) (Issuer)
- Chief Scientific Officer Mata Nathan L. sold $159,162 worth of American depositary share (1,000 units at $159.16) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 6,666 units (SEC Form 4)4 - BELITE BIO, INC (0001889109) (Issuer)
- Chief Scientific Officer Mata Nathan L. sold $162,641 worth of American depositary share (1,000 units at $162.64) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 7,666 units (SEC Form 4)4 - BELITE BIO, INC (0001889109) (Issuer)
- Chief Scientific Officer Mata Nathan L. sold $159,556 worth of American depositary share (1,000 units at $159.56) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 8,666 units (SEC Form 4)4 - BELITE BIO, INC (0001889109) (Issuer)
- Chief Scientific Officer Mata Nathan L. sold $166,284 worth of American depositary share (1,000 units at $166.28) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 9,666 units (SEC Form 4)4 - BELITE BIO, INC (0001889109) (Issuer)
- Chief Executive Officer Lin Yu-Hsin acquired 10,000 units of Ordinary Share, increasing direct ownership by 6% to 182,949 units (SEC Form 4)4 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Scholl Hendrik Peter4 - BELITE BIO, INC (0001889109) (Issuer)
- Chief Scientific Officer Mata Nathan L. sold $170,384 worth of American depositary share (1,000 units at $170.38) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 10,666 units (SEC Form 4)4 - BELITE BIO, INC (0001889109) (Issuer)
- Chief Financial Officer Chuang Hao-Yuan acquired 10,000 units of Ordinary Share, increasing direct ownership by 5% to 205,264 units (SEC Form 4)4 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 4 filed by Mata Nathan L.4 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 4 filed by Mata Nathan L.4 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 4 filed by Mata Nathan L.4 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 4 filed by Mata Nathan L.4 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 4 filed by Mata Nathan L.4 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 4 filed by Chen Wan-Shan4 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 4 filed by Lin Yu-Hsin4 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 4 filed by Chuang Hao-Yuan4 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 4 filed by Chen Wan-Shan4 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 4 filed by Chuang Hao-Yuan4 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 4 filed by Mata Nathan L.4 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 4 filed by Lin Yu-Hsin4 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 3 filed by new insider Scholl Hendrik Peter3 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 3 filed by new insider Mata Nathan L.3 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 3 filed by new insider Chuang Hao-Yuan3 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 3 filed by new insider Chen Xiao-Hui3 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 3 filed by new insider Longo John Michael3 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 3 filed by new insider Lu Ita3 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 3 filed by new insider Biddle Gary Clark3 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 3 filed by new insider Lin Yu-Hsin3 - BELITE BIO, INC (0001889109) (Issuer)
- SEC Form 3 filed by new insider Chen Wan-Shan3 - BELITE BIO, INC (0001889109) (Issuer)